中国科学: 化学 2014年 第44卷 第5期

on online affinity solid phase extraction-high performance liquid chromatography and ultra performance liquid chromatography-mass spectrometry. Mol Biosyst, 2010, 6: 1947–1955

48 Xu G, Di Stefano C, Liebich HM, Zhang Y, Lu P. Reversed-phase high-performance liquid chromatographic investigation of urinary normal

and modified nucleosides of cancer patients. J Chromatogr B, 1999, 732: 307–313

49 Zhao XJ, Wang WZ, Wang JS, Yang J, Xu GW. Urinary profiling investigation of metabolites with cis-diol structure from cancer patients

based on UPLC-MS and HPLC-MS as well as multivariate statistical analysis. J Sep Sci, 2006, 29: 2444–2451

50 Gu Y, Lu C, Zha QL, Kong HW, Lu X, Lu AP, Xu GW. Plasma metabonomics study of rheumatoid arthritis and its Chinese medicine

subtypes by using liquid chromatography and gas chromatography coupled with mass spectrometry. Mol Biosyst, 2012, 8: 1535–1543 51 He HB, Ren XB, Wang XY, Shi XZ, Wang XL, Ding ZJ, Gao P, Xu GW. Therapeutic effect of Yunnan Baiyao on rheumatoid arthritis was

partially due to regulating arachidonic acid metabolism in osteoblasts. J Pharmaceut Biomed Anal, 2012, 59: 130–137

52 Zhao XJ, Zhang Y, Meng XL, Yin PY, Deng C, Chen J, Wang Z, Xu GW. Effect of a traditional Chinese medicine preparation Xindi soft

capsule on rat model of acute blood stasis: a urinary metabonomics study based on liquid chromatography-mass spectrometry. J Chromatogr B, 2008, 873: 151–158

53 Zhou J, Zhang L, Chang YW, Lu X, Zhu Z, Xu GW. Alteration of leaf metabolism in Bt-transgenic rice (Oryza sativa L.) and its wild type

under insecticide stress. J Proteome Res, 2012, 11: 4351–4360

54 Chang YW, Zhao CX, Zhu Z, Wu ZM, Zhou J, Zhao YN, Lu X, Xu GW. Metabolic profiling based on LC/MS to evaluate unintended

effects of transgenic rice with cry1Ac and sck genes. Plant Mol Biol, 2012, 78: 477–487

55 Wu R, Wu ZM, Wang XH, Yang PC, Yu D, Zhao CX, Xu GW, Kang L. Metabolomic analysis reveals that carnitines are key regulatory

metabolites in phase transition of the locusts. Proc Natl Acad Sci USA, 2012, 109: 3259–3263

56 Li J, Hoene M, Zhao XJ, Chen SL, Wei H, Häring HU, Lin XH, Zeng ZD, Weigert C, Lehmann R, Xu GW. Stable isotope-assisted

lipidomics combined with nontargeted isotopomer filtering, a tool to unravel the complex dynamics of lipid metabolism. Anal Chem, 2013, 85: 4651–4657

57 Wolf M, Chen S, Zhao X, Scheler M, Irmler M, Staiger H, Beckers J, de Angelis MH, Fritsche A, Häring HU, Schleicher ED, Xu GW,

Lehmann R, Weigert C. Production and release of acylcarnitines by primary myotubes reflect the differences in fasting fat oxidation of the donors. J Clin Endocrinol Metab, 2013, 98: E1137–E1142

58 Lehmann R, Franken H, Dammeier S, Rosenbaum L, Kantartzis K, Peter A, Zell A, Adam P, Li J, Xu GW, Konigsrainer A, Machann J,

Schick F, Hrabe de Angelis M, Schwab M, Staiger H, Schleicher E, Gastaldelli A, Fritsche A, Haring HU, Stefan N. Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. Diabetes Care, 2013, 36: 2331–2338

59 Xu J, Chen YH, Zhang RP, Song YM, Cao JZ, Bi N, Wang JB, He JM, Bai JF, Dong LJ, Wang LH, Zhan QM, Abliz Z. Global and targeted

metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers. Mol Cell Proteomics, 2013, 12: 1306–1318

60 An ZL, Chen YH, Zhang RP, Song YM, Sun JH, He JM, Bai JF, Dong LJ, Zhan QM, Abliz Z. Integrated ionization approach for

RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer. J Proteome Res, 2010, 9: 4071–4081

61 Chen YH, Zhang RP, Song YM, He JM, Sun JH, Bai JF, An ZL, Dong LJ, Zhan QM, Abliz Z. RRLC-MS/MS-based metabonomics

combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer. Analyst, 2009, 134: 2003–2011

62 Chen YH, Xu J, Zhang RP, Shen GQ, Song YM, Sun JH, He JM, Zhan QM, Abliz Z. Assessment of data pre-processing methods for

LC-MS/MS-based metabolomics of uterine cervix cancer. Analyst, 2013, 138: 2669–2677

63 Chen YH, Shen G,Q Zhang RP, He JM, Zhang Y, Xu J, Yang W, Chen XJ, Song YM, Abliz Z. Combination of injection volume calibration

by creatinine and MS signals’ normalization to overcome urine variability in LC-MS-based metabolomics studies. Anal Chem, 2013, 85: 7659–7665

64 Shen GQ, Chen YH, Sun JH, Zhang RP, Zhang Y, He JM, Tian YP, Song YM, Chen XJ, Abliz Z. Time-course changes in potential

biomarkers detected using a metabonomic approach in Walker 256 tumor-bearing rats. J Proteome Res, 2011, 10: 1953–1961

65 Yang W, Chen YH, Xi C, Zhang RP, Song YM, Zhan QM, Bi XF, Abliz Z. Liquid chromatography-tandem mass spectrometry-based

plasma metabonomics delineate the effect of metabolites’ stability on reliability of potential biomarkers. Anal Chem, 2013, 85: 2606–2610 66 Li SF, Liu HX, Jin YB, Lin SH, Cai ZW, Jiang YY. Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma

xenografts in mice. J Chromatogr B, 2011, 879: 2369–2375

67 Lin SH, Kanawati B, Liu LF, Witting M, Li M, Huang JD, Schmitt-Kopplin P, Cai ZW. Ultrahigh resolution mass spectrometry-based

metabolic characterization reveals cerebellum as a disturbed region in two animal models. Talanta, 2014, 118: 45–53

729